Improved knowledge on consumption, emissions, environmental levels and risks associated with pharmaceuticals.
1. Sources and environmental levels of pharmaceuticals
Objective
- Increase knowledge about sources, pathways and occurrence of pharmaceuticals
Activities
- Case studies in selected river basin districts
- Mapping of human and veterinary consumption; emissions from wastewater treatment plants, manufacturing facilities, hospitals, fish and livestock farms; environmental levels
- Literature studies and chemical analyses
2. Environmental risk assessment of pharmaceuticals
Objectives
- Estimate environmental risks of active pharmaceutical ingredients in the Baltic Sea Region
- Point out the most environmentally risky compounds
Activities
- Assessing consumption and occurrence data from previous part of the Work package
- Screening of ecotoxicity data
- New ecotoxicity testing when considered necessary
3. Upscaling of screening data to Baltic Sea region
Objectives
- Increase knowledge about the overall emissions and concentrations of selected pharmaceuticals in the Baltic Sea Region
- Indicate areas with the highest pharmaceutical concentrations and possible emission hot spots
Activities
- Using a GIS-based calculation system and available data from each participating country
- Estimating loads and concentrations
4. Output
- Comprehensive status report on pharmaceuticals in the Baltic Sea Region
WP2 leader: Helene Ek-Henning, County Administrative Board of Östergötland (CAB)
Partners
- County Administrative Board of Östergötland (CAB)
- Finnish Environment Institute (SYKE)
- Finnish Medicines Agency (Fimea)
- Estonian Environmental Research Centre (EERC)
- Estonian Waterworks Association (EVEL)
- Berlin Centre of Competence for Water (KWB)
- German Association for Water, Wastewater and Waste (DWA)
- Institute of Environmental Protection – National Research Institute (IOS)
- Latvian Institute of Aquatic Ecology (LIAE)
- Latvian Environment, Geology and Meteorology Centre (LEGMC)